Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
3.1.2 Exenatide As the first GLP-1R agonist approved for T2DM, EX is a new class of compound and a synthetic product of exendin-4, which is a compound naturally derived from the Gila monster and has multiple hypoglycemic mechanisms: inhibiting of glucagon release from cells, slowing of gastric emptying, decreasing appetite and increasing glucose-dependent insulin secretion ( Lipotoxicity induced by saturated free fatty acids plays a vital role in renal injury in obese patients ( There is little research on the weight loss effect of EX on simple obesity patients, and more clinical trials are conducted on patients with T2DM
Download our pharmacist-reviewed guide designed to answer all your questions about GLP-1 medicationsfrom how to store and inject your medication correctly, to tips for traveling and avoiding common mistakesso you can feel confident and supported at every step
INSTRUMENTAL TEST* CLINICAL TEST** **Instrumental and clinical tests conducted by an independent laboratory on 20 volunteers, aged 30-60 years
Let's see if we were able to reverse your prediabetes
*Lu : Hiu qu sn phm cn ph thuc vo c a ca mi ngi
Guedj et al
